Company / Total Debt
CG Oncology, Inc. Total Debt History
FY2024-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Total Debt
$3.0M
FY2025
5-year range
$0 / $3.0M
FY2024-FY2025
Trend
-
vs FY2024
Sector context
#79 of 83
Health Care
What the data says
Among 83 Health Care companies, CG Oncology, Inc. is in the top 5% for total debt.
Based on SEC 10-K filings.
$3M in FY2025.
Health Care sector context is included.
Total Debt over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Top 5% in Health CareTop 5% of 83This company $3.0M Sector average $6.2B
▼
-100.0% below sector average
Key checks
Key Insights
- Ranks #79 out of 83 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 8.02 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Total DebtValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $3.0M | - |
| FY2024 | $0 | - |
| FY2023 | - | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026